2025刚开年,全球骨科巨头史赛克(Stryker)就率先发起了医疗领域第一笔超10亿美元的重磅并购!1月6日,史赛克宣布与外周介入领域企业Inari Medical达成最终协议:以每股80美元现金收购Inari Medical的所有已发行和流通在外的普通股,完全摊薄后的股票总价值约49亿美元(人民币约360亿元)。作为全球骨科巨头,史赛克的一举一动都受到大量从业者的关注,尤其是在史赛克去年1年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.